Neogen Revenue 2012-2025 | NEOG
Neogen revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Neogen Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $895 |
| 2024 | $924 |
| 2023 | $822 |
| 2022 | $527 |
| 2021 | $468 |
| 2020 | $418 |
| 2019 | $414 |
| 2018 | $398 |
| 2017 | $358 |
| 2016 | $321 |
| 2015 | $283 |
| 2014 | $247 |
| 2013 | $208 |
| 2012 | $184 |
| 2011 | $173 |
|
Neogen Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-08-31 | $209 |
| 2025-05-31 | $225 |
| 2025-02-28 | $221 |
| 2024-11-30 | $231 |
| 2024-08-31 | $217 |
| 2024-05-31 | $237 |
| 2024-02-29 | $229 |
| 2023-11-30 | $230 |
| 2023-08-31 | $229 |
| 2023-05-31 | $242 |
| 2023-02-28 | $218 |
| 2022-11-30 | $230 |
| 2022-08-31 | $132 |
| 2022-05-31 | $140 |
| 2022-02-28 | $128 |
| 2021-11-30 | $131 |
| 2021-08-31 | $128 |
| 2021-05-31 | $127 |
| 2021-02-28 | $117 |
| 2020-11-30 | $115 |
| 2020-08-31 | $109 |
| 2020-05-31 | $109 |
| 2020-02-29 | $100 |
| 2019-11-30 | $108 |
| 2019-08-31 | $101 |
| 2019-05-31 | $110 |
| 2019-02-28 | $98 |
| 2018-11-30 | $107 |
| 2018-08-31 | $100 |
| 2018-05-31 | $108 |
| 2018-02-28 | $95 |
| 2017-11-30 | $101 |
| 2017-08-31 | $94 |
| 2017-05-31 | $96 |
| 2017-02-28 | $88 |
| 2016-11-30 | $91 |
| 2016-08-31 | $84 |
| 2016-05-31 | $90 |
| 2016-02-29 | $77 |
| 2015-11-30 | $80 |
| 2015-08-31 | $75 |
| 2015-05-31 | $79 |
| 2015-02-28 | $68 |
| 2014-11-30 | $68 |
| 2014-08-31 | $68 |
| 2014-05-31 | $67 |
| 2014-02-28 | $62 |
| 2013-11-30 | $60 |
| 2013-08-31 | $59 |
| 2013-05-31 | $56 |
| 2013-02-28 | $51 |
| 2012-11-30 | $51 |
| 2012-08-31 | $50 |
| 2012-05-31 | $49 |
| 2012-02-29 | $45 |
| 2011-11-30 | $45 |
| 2011-08-31 | $46 |
| 2011-05-31 | $44 |
| 2011-02-28 | $42 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.491B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.159B | 25.14 |
| EssilorLuxottica (ESLOY) | France | $153.653B | 0.00 |
| Boston Scientific (BSX) | United States | $137.244B | 31.38 |
| Stryker (SYK) | United States | $135.413B | 26.89 |
| Medtronic (MDT) | Ireland | $128.035B | 17.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.403B | 0.00 |
| Agilent Technologies (A) | United States | $39.599B | 25.03 |
| GE HealthCare Technologies (GEHC) | United States | $38.246B | 18.29 |
| ResMed (RMD) | United States | $36.817B | 25.48 |
| Koninklijke Philips (PHG) | Netherlands | $25.633B | 16.74 |
| Terumo (TRUMY) | Japan | $21.631B | 24.35 |
| Insulet (PODD) | United States | $20.802B | 64.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.151B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.847B | 0.00 |
| Baxter (BAX) | United States | $9.844B | 7.95 |
| Sunny Optical Technology (SNPTF) | China | $9.054B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.312B | 29.89 |
| Demant (WILYY) | Denmark | $7.038B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.418B | 13.46 |
| Haemonetics (HAE) | United States | $3.908B | 17.39 |
| ICU Medical (ICUI) | United States | $3.664B | 23.26 |
| Envista Holdings (NVST) | United States | $3.612B | 20.73 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.954B | 13.47 |
| Curaleaf Holdings (CURLF) | Canada | $2.523B | 0.00 |
| AtriCure (ATRC) | United States | $2.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.011B | 88.14 |
| QuidelOrtho (QDEL) | United States | $1.956B | 12.58 |
| LeMaitre Vascular (LMAT) | United States | $1.906B | 38.36 |
| Perrigo (PRGO) | Ireland | $1.808B | 4.53 |
| Phibro Animal Health (PAHC) | United States | $1.627B | 16.26 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Tilray Brands (TLRY) | Canada | $1.364B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.346B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.190B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 348.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.921B | 0.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| CeriBell (CBLL) | United States | $0.776B | 0.00 |
| Valneva SE (VALN) | France | $0.746B | 0.00 |
| Omeros (OMER) | United States | $0.720B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.641B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.581B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.509B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 13.31 |
| Evolus (EOLS) | United States | $0.456B | 0.00 |
| BillionToOne (BLLN) | United States | $0.456B | 0.00 |
| Cerus (CERS) | United States | $0.419B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.365B | 0.00 |
| Quanterix (QTRX) | United States | $0.353B | 0.00 |
| Brainsway (BWAY) | Israel | $0.332B | 56.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 180.00 |
| TerrAscend (TSNDF) | Canada | $0.280B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 21.88 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Organigram Global (OGI) | Canada | $0.259B | 0.00 |
| High Tide (HITI) | Canada | $0.255B | 0.00 |
| Owens & Minor (OMI) | United States | $0.233B | 2.33 |
| Sanara MedTech (SMTI) | United States | $0.231B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.41 |
| OraSure Technologies (OSUR) | United States | $0.179B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.169B | 20.77 |
| Exagen (XGN) | United States | $0.161B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.156B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| Biote (BTMD) | United States | $0.123B | 5.40 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.29 |
| MacroGenics (MGNX) | United States | $0.089B | 0.00 |
| Sharps Technology (STSS) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 23.88 |
| Nephros (NEPH) | United States | $0.053B | 38.62 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Veru (VERU) | United States | $0.035B | 0.00 |
| Jin Medical (ZJYL) | China | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.02 |
| Zynex (ZYXI) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |